Welcome to the Executive Edge.
Here we offer solution companies insights on issues facing health system executives today - all based on our extensive executive and health system intelligence. Use these insights to spark conversations, demonstrate your knowledge of industry trends, and position your company as a valuable partner to health systems.
This week’s newsletter is 1,779 words or a 7-minute read.
Key Takeaways:
Inside The Rise of the Patient Payer: As healthcare consumers shoulder more financial responsibility, new opportunities are emerging in health insurance - ancillary financing and cash-pay services. Health systems that adapt to this consumer-driven shift by offering transparent pricing and patient-friendly options will stand out, but they will seek partners who can support these changes effectively.
Compounded GLP-1s Compounding Shortage Complexity: With the demand for GLP-1 drugs like Ozempic and Wegovy soaring, compounding pharmacies are stepping in to address shortages. However, while these compounded versions offer a temporary solution at a lower cost, they also bring significant regulatory risks and potential safety concerns. The compounded GLP-1 market remains volatile, with legal battles brewing and looming changes as branded drug production ramps up.
How Healthcare Leaders Are Navigating 2024’s Top Financial Challenges: Healthcare executives are facing mounting revenue cycle pressures, with payer denials and staffing shortages at the forefront. A recent Guidehouse and HFMA report highlights how organizations are addressing these pain points through outsourcing, tech investment, and improving patient access to boost financial performance.